Arteriosclerosis
Not yet recruitingStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
- Disease:Arteriosclerosis
- Substances:–
Italy- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Italy21 clinical trials in Acquaviva Delle Fonti, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on type 2 diabetes and cardiovascular prevention, including evaluation of colchicine and aspirin combinations for improving outcomes in high-risk patients.
Additional research examining atrial fibrillation treatments for stroke prevention using novel anticoagulation approaches.
Comprehensive research in multiple cancer types, including ovarian cancer, prostate cancer, and thoracic malignancies.
Novel therapeutic approaches including maintenance treatments and combination therapies for various cancer stages.
Focused research on rare conditions including Hereditary Angioedema and specialized treatments for bladder cancer.
Including studies on IgA nephropathy treatment strategies and innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.